Lilly's Mounjaro shows heart health benefits in head-to-head trial with Trulicity
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
The SURPASS-CVOT study met its primary objective by demonstrating that Mounjaro (tirzepatide) was non-inferior to Trulicity
A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Singhal brings a powerful blend of operational excellence, investor acumen, and visionary thinking
The campaign celebrates radiant, healthy skin that shines naturally, empowering women to step forward with confidence in every walk of life.
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
The Medical Countermeasures Strategy focuses on strengthening the EU’s preparedness for health crises
Commercial production is expected to begin soon
Surpassing 1,000 Company Owned Company Operated stores
Subscribe To Our Newsletter & Stay Updated